An evolutionary conserved Hexim1 peptide binds to the Cdk9 catalytic site to inhibit P-TEFb.
Résumé
The positive transcription elongation factor (P-TEFb) is required for the
transcription of most genes by RNA polymerase II. Hexim proteins associated with
7SK RNA bind to P-TEFb and reversibly inhibit its activity. P-TEFb comprises the
Cdk9 cyclin-dependent kinase and a cyclin T. Hexim proteins have been shown to
bind the cyclin T subunit of P-TEFb. How this binding leads to inhibition of the
kinase activity of Cdk9 has remained elusive, however. Using a photoreactive
amino acid incorporated into proteins, we show that in live cells, cell extracts,
and in vitro reconstituted complexes, Hexim1 cross-links and thus contacts Cdk9.
Notably, replacement of a phenylalanine, F208, belonging to an evolutionary
conserved Hexim1 peptide ((202)PYNTTQFLM(210)) known as the "PYNT" sequence,
cross-links a peptide within the activation segment that controls access to the
Cdk9 catalytic cleft. Reciprocally, Hexim1 is cross-linked by a photoreactive
amino acid replacing Cdk9 W193, a tryptophan within this activation segment.
These findings provide evidence of a direct interaction between Cdk9 and its
inhibitor, Hexim1. Based on similarities with Cdk2 3D structure, the Cdk9 peptide
cross-linked by Hexim1 corresponds to the substrate binding-site. Accordingly,
the Hexim1 PYNT sequence is proposed to interfere with substrate binding to Cdk9
and thereby to inhibit its kinase activity.